Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Compound (I). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107108681B reveals a high-purity nucleoside analog synthesis route eliminating chromatography, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN102180836B reveals a safer, cost-effective method for synthesizing kinase inhibitor intermediates, offering significant supply chain advantages.
Novel synthesis of benzimidazole compound (I) via late-stage Suzuki coupling. Reduces cost and improves scalability for oncology intermediates.
Patent CN114085146A reveals a metal-free method for high-yield substituted acrylate synthesis, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN112390816B discloses a scalable synthesis of oxazepine derivatives for Hepatitis B treatment, offering improved yield and safety for API manufacturing.
Novel 2-step synthesis of Montelukast intermediate via Wittig and Pd-coupling. Reduces cost and steps for API manufacturing.